BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
-0.01%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$6.89B
AUM Growth
+$6.89B
(-8.5%)
Cap. Flow
-$366M
Cap. Flow
% of AUM
-5.31%
Top 10 Holdings %
Top 10 Hldgs %
36.47%
Holding
178
New
7
Increased
49
Reduced
68
Closed
19
Top Buys
| 1 |
Medtronic
MDT
|
$49.2M |
| 2 |
Align Technology
ALGN
|
$30.7M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$15.6M |
| 4 |
Veeva Systems
VEEV
|
$14.1M |
| 5 |
Legend Biotech
LEGN
|
$7.35M |
Top Sells
| 1 |
MYOV
Myovant Sciences Ltd.
MYOV
|
$159M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
$27.3M |
| 3 |
DexCom
DXCM
|
$27.1M |
| 4 |
Cigna
CI
|
$26.9M |
| 5 |
Elevance Health
ELV
|
$26M |
Sector Composition
| 1 | Healthcare | 99.07% |
| 2 | Industrials | 0.84% |
| 3 | Energy | 0.03% |
| 4 | Communication Services | 0.01% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Elevance Health
ELV
$72.4B
| $42.7M | 0.62% |
92,970
-56,451
| -38% | -$26M |
|
|
SILK
52
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $41.9M | 0.61% |
1,069,739
+57,216
| +6% | +$2.24M |
|
53
CRISPR Therapeutics
CRSP
$4.82B
| $40.7M | 0.59% |
899,800
-11,905
| -1% | -$538K |
|
|
AMED
54
DELISTED
Amedisys
AMED
| $39.9M | 0.58% |
542,616
-70,896
| -12% | -$5.21M |
|
55
Molina Healthcare
MOH
$9.6B
| $38.1M | 0.55% |
142,609
-43,405
| -23% | -$11.6M |
|
56
Globus Medical
GMED
$7.94B
| $36.7M | 0.53% |
647,645
-32,535
| -5% | -$1.84M |
|
57
Centene
CNC
$14.8B
| $34.7M | 0.5% |
549,341
-144,217
| -21% | -$9.12M |
|
58
IQVIA
IQV
$31.4B
| $34.3M | 0.5% |
172,478
-10,842
| -6% | -$2.16M |
|
59
Zimmer Biomet
ZBH
$20.8B
| $34.3M | 0.5% |
265,270
-1,026
| -0.4% | -$133K |
|
60
Humana
HUM
$37.5B
| $33.3M | 0.48% |
68,570
-41,969
| -38% | -$20.4M |
|
61
CareDx
CDNA
$678M
| $31.4M | 0.46% |
3,439,091
+270,643
| +9% | +$2.47M |
|
62
Cooper Companies
COO
$13.3B
| $30.4M | 0.44% |
81,313
| – | – |
|
63
Pfizer
PFE
$141B
| $30.2M | 0.44% |
740,695
-47,978
| -6% | -$1.96M |
|
64
Halozyme
HALO
$8.75B
| $28.4M | 0.41% |
742,400
-70,300
| -9% | -$2.68M |
|
65
Privia Health
PRVA
$2.84B
| $27.7M | 0.4% |
1,002,644
+101,978
| +11% | +$2.82M |
|
66
Fate Therapeutics
FATE
$115M
| $27.7M | 0.4% |
4,855,779
-5,500
| -0.1% | -$31.4K |
|
67
Axsome Therapeutics
AXSM
$6.09B
| $27.2M | 0.4% |
441,350
+4,692
| +1% | +$289K |
|
68
Omnicell
OMCL
$1.51B
| $27.2M | 0.39% |
463,367
-55,017
| -11% | -$3.23M |
|
69
AtriCure
ATRC
$1.73B
| $26.8M | 0.39% |
647,222
+3,113
| +0.5% | +$129K |
|
70
BioNTech
BNTX
$24.1B
| $24.5M | 0.36% |
196,480
-24,600
| -11% | -$3.06M |
|
|
71
Legend Biotech
LEGN
$6.64B
| $24.5M | 0.35% |
507,254
+152,465
| +43% | +$7.35M |
|
72
HUTCHMED
HCM
$2.62B
| $23.8M | 0.35% |
1,826,970
+46,826
| +3% | +$610K |
|
73
ESSA Pharma
EPIX
$11.2M
| $23.5M | 0.34% |
7,898,583
| – | – |
|
74
Hologic
HOLX
$14.7B
| $23.4M | 0.34% |
290,136
+46,965
| +19% | +$3.79M |
|
75
Illumina
ILMN
$15.2B
| $23.1M | 0.34% |
99,257
+4,350
| +5% | +$1.01M |
|